Buchanan Ingersoll & Rooney PC
EP4 antagonists
We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
Eisai R&D Management Co., Ltd.
C A C
C07D A61P C07D
inventional inventional inventional
Frank Daniel Jing Yimin Maarten Hyeong-wook Xiaojie Robert Wanjun Jaemoon Hong
Fang Custar Li Jiang Postema Choi Zhu Yu Zheng Lee Du